MARINUS PHARMACEUTICALS, INC. Interest Expense Nonoperating
MARINUS PHARMACEUTICALS, INC. reported Interest Expense Nonoperating of $3.84 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2024-11-12
- MARINUS PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2024-09-30 was $3.84M, a 9.41% decline year-over-year.
- MARINUS PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2024-06-30 was $4.62M, a 9.72% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2023-09-30 was $4.24M.
- MARINUS PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2023-06-30 was $4.21M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month |
|---|---|---|---|
| 2024-09-30 | $3.84M 10-Q · filed 2024-11-12 | $8.46M derived: sum of 2 quarters · filed 2024-11-12 | $12.81M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.62M 10-Q · filed 2024-08-13 | $8.96M 10-Q · filed 2024-08-13 | |
| 2023-09-30 | $4.24M 10-Q · filed 2024-11-12 | $8.45M derived: sum of 2 quarters · filed 2024-11-12 | $12.60M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $4.21M 10-Q · filed 2024-08-13 | $8.36M 10-Q · filed 2024-08-13 |